Browsing by Author "Mirgayazova R."

Sort by: Order: Results:

  • Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy 
    Chasov V.; Mirgayazova R.; Zmievskaya E.; Khadiullina R.; Valiullina A.; Stephenson Clarke J.; Rizvanov A.; Baud M.G.J.; Bulatov E. (2020)
    © Copyright © 2020 Chasov, Mirgayazova, Zmievskaya, Khadiullina, Valiullina, Stephenson Clarke, Rizvanov, Baud and Bulatov. The transcription factor p53 is a key tumor suppressor that is inactivated in almost all cancers ...
  • Novel Isatin-based activator of p53 transcriptional functions in tumor cells 
    Mirgayazova R.; Khadiullina R.; Mingaleeva R.; Chasov V.; Gomzikova M.; Garanina E.; Rizvanov A.; Bulatov E. (2019)
    © 2019 Shiraz University. Bioinorganic medicinal chemistry remains a hot field for research aimed at developing novel anti-cancer treatments. Discovery of metal complexes as potent antitumor chemotherapeutics such as ...
  • Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies 
    Chasov V.; Zaripov M.; Mirgayazova R.; Khadiullina R.; Zmievskaya E.; Ganeeva I.; Valiullina A.; Rizvanov A.; Bulatov E. (2021)
    Transcription factor and oncosuppressor protein p53 is considered as one of the most promising molecular targets that remains a high-hanging fruit in cancer therapy. TP53 gene encoding the p53 protein is known to be the ...
  • Therapeutic editing of the TP53 gene: Is crispr/CAS9 an option? 
    Mirgayazova R.; Khadiullina R.; Chasov V.; Mingaleeva R.; Miftakhova R.; Rizvanov A.; Bulatov E. (2020)
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. The TP53 gene encodes the transcription factor and oncosuppressor p53 protein that regulates a multitude of intracellular metabolic pathways involved in DNA damage ...

Search DSpace

Browse

My Account